Effect of antihypertensive therapy on development of incident conduction system disease in hypertensive patients
Conclusion:
Incident IVCD, but not BBB, is significantly reduced by losartan-based treatment. Further study is warranted to assess the potential differential impact of this therapy on QRS prolongation vs. development of more discrete conduction system block.
Clinical Trials Registration:
http://clinicaltrials.gov/ct/show/NCT00338260?order=1
Source: Journal of Hypertension - Category: Cardiology Tags: ORIGINAL PAPERS: Treatment Source Type: research
More News: Atenolol | Atrial Fibrillation | Cardiology | Cholesterol | Clinical Trials | Cozaar | Diabetes | Electrocardiogram | Endocrinology | Heart | Heart Disease | Heart Failure | Hypertension | Lisinopril | Losartan | Statistics | Study